New immunotherapeutic approaches for cancer treatment

Pathol Res Pract. 2023 Aug:248:154632. doi: 10.1016/j.prp.2023.154632. Epub 2023 Jun 19.

Abstract

Neoplasms are a worldwide recognized non-contagious disease which has the most mortality rate after cardiovascular diseases. For decades, there has been a vast amount of study on treatment methods of cancer which has led to conventional therapies such as chemotherapy, radiation therapy, surgery and so on. Clinicians and researchers believed that there is an urgent need, considering the high rate of incidence and prevalence, for an alternative treatment option which is more efficacious and has less adverse effects than the above-mentioned treatments. Immunotherapy has emerged as a potential treatment alternative in a few years and became one of the fastest developing therapeutic approaches. Different kinds of immunotherapies are FDA approved and available for treatment of various cancer types. In this review, we have summarized the major immunotherapy methods including checkpoint inhibitors, CAR T cell therapies and cancer vaccines. Furthermore, application of combination therapy, precision medicine, biomarker discovery, overcoming resistance and reduction of adverse effects are discussed in this study.

Keywords: CAR T cell therapy; Cancer vaccines; Immune checkpoint inhibitors; Immunotherapy.

Publication types

  • Review

MeSH terms

  • Cancer Vaccines
  • Humans
  • Immune Checkpoint Inhibitors
  • Immunotherapy*
  • Immunotherapy, Adoptive
  • Neoplasms* / therapy
  • Precision Medicine

Substances

  • Immune Checkpoint Inhibitors
  • Cancer Vaccines